Chlorine in PDB 8ogc: Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11

Enzymatic activity of Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11

All present enzymatic activity of Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11:
2.7.11.1;

Protein crystallography data

The structure of Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11, PDB code: 8ogc was solved by M.Schroeder, A.Vulpetti, M.Renatus, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 70.89 / 2.09
Space group P 61 2 2
Cell size a, b, c (Å), α, β, γ (°) 81.74, 81.74, 234.101, 90, 90, 120
R / Rfree (%) 17.1 / 20.2

Other elements in 8ogc:

The structure of Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11 also contains other interesting chemical elements:

Magnesium (Mg) 1 atom

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11 (pdb code 8ogc). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11, PDB code: 8ogc:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 8ogc

Go back to Chlorine Binding Sites List in 8ogc
Chlorine binding site 1 out of 2 in the Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1506

b:34.0
occ:1.00
CL24 A:VMZ1506 0.0 34.0 1.0
C16 A:VMZ1506 1.7 29.0 1.0
C17 A:VMZ1506 2.6 27.0 1.0
C15 A:VMZ1506 2.7 28.5 1.0
HB2 A:ARG1298 3.0 33.8 1.0
HD13 A:ILE1262 3.0 25.7 1.0
HD22 A:LEU1313 3.1 32.7 1.0
HB3 A:ARG1225 3.2 29.1 1.0
HO2 A:EDO1505 3.2 33.9 1.0
HG3 A:ARG1225 3.3 32.7 1.0
HD12 A:ILE1262 3.3 26.2 1.0
HD11 A:ILE1262 3.4 25.6 1.0
CD1 A:ILE1262 3.4 26.0 1.0
HE1 A:PHE1330 3.5 33.5 1.0
H22 A:EDO1505 3.6 36.5 1.0
HD2 A:ARG1298 3.6 37.8 1.0
HD12 A:LEU1313 3.6 33.2 1.0
HB2 A:ARG1225 3.7 29.6 1.0
CB A:ARG1225 3.8 29.8 1.0
HG3 A:ARG1298 3.8 35.3 1.0
CB A:ARG1298 3.8 33.8 1.0
H12 A:EDO1505 3.9 38.5 1.0
C18 A:VMZ1506 3.9 29.0 1.0
CD2 A:LEU1313 3.9 33.4 1.0
O2 A:EDO1505 4.0 32.5 1.0
HG A:LEU1313 4.0 32.7 1.0
CG A:ARG1225 4.0 32.5 1.0
C14 A:VMZ1506 4.0 29.9 1.0
HD23 A:LEU1313 4.1 33.1 1.0
C2 A:EDO1505 4.1 37.5 1.0
HA A:ARG1298 4.2 32.3 1.0
HZ A:PHE1330 4.2 33.7 1.0
CG A:ARG1298 4.2 34.6 1.0
CG A:LEU1313 4.3 33.2 1.0
CE1 A:PHE1330 4.3 33.4 1.0
CD A:ARG1298 4.4 39.2 1.0
CD1 A:LEU1313 4.4 34.0 1.0
CA A:ARG1298 4.4 32.8 1.0
C13 A:VMZ1506 4.5 28.3 1.0
C1 A:EDO1505 4.5 38.7 1.0
HD2 A:ARG1225 4.6 35.1 1.0
HB3 A:ARG1298 4.6 34.0 1.0
H A:ARG1298 4.6 31.9 1.0
N A:ARG1298 4.6 31.8 1.0
CZ A:PHE1330 4.7 34.6 1.0
HD21 A:LEU1313 4.7 33.5 1.0
HG2 A:ARG1225 4.7 33.2 1.0
HA A:ILE1262 4.7 25.1 1.0
O A:ARG1225 4.8 25.1 1.0
CD A:ARG1225 4.8 35.7 1.0
CG1 A:ILE1262 4.9 26.3 1.0
HD11 A:LEU1313 4.9 34.0 1.0
H11 A:EDO1505 5.0 38.5 1.0
HD3 A:ARG1298 5.0 38.0 1.0

Chlorine binding site 2 out of 2 in 8ogc

Go back to Chlorine Binding Sites List in 8ogc
Chlorine binding site 2 out of 2 in the Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Crystal Structure of Human DCAF1 WD40 Repeats (Q1250L) in Complex with Compound 11 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl1507

b:59.9
occ:1.00
CL24 A:VMZ1507 0.0 59.9 1.0
C16 A:VMZ1507 1.7 57.4 1.0
HG A:LEU1117 2.6 26.7 0.5
C17 A:VMZ1507 2.7 47.2 1.0
HD23 A:LEU1117 2.7 27.3 0.5
C15 A:VMZ1507 2.7 50.4 1.0
O A:LEU1117 3.2 26.4 0.5
O A:LEU1117 3.2 25.1 0.5
HB2 A:TYR1131 3.3 27.4 1.0
CG A:LEU1117 3.3 26.0 0.5
CD2 A:LEU1117 3.4 27.0 0.5
HB3 A:LEU1117 3.4 28.8 0.5
HB3 A:LEU1117 3.4 25.6 0.5
H A:TYR1131 3.6 26.9 1.0
HB3 A:TYR1131 3.6 26.5 1.0
HA A:LYS1118 3.6 28.1 1.0
HA A:SER1130 3.7 30.9 1.0
C A:LEU1117 3.7 25.2 0.5
C A:LEU1117 3.7 26.8 0.5
N A:TYR1131 3.7 26.7 1.0
HB2 A:LEU1117 3.8 28.9 0.5
HD22 A:LEU1117 3.8 26.9 0.5
C A:SER1130 3.8 30.0 1.0
CB A:LEU1117 3.8 25.3 0.5
CB A:TYR1131 3.9 26.8 1.0
C18 A:VMZ1507 4.0 49.6 1.0
N A:SER1130 4.0 32.2 1.0
CA A:SER1130 4.0 31.8 1.0
C14 A:VMZ1507 4.0 53.5 1.0
CB A:LEU1117 4.0 28.8 0.5
HB3 A:ALA1129 4.1 34.7 1.0
N A:LYS1118 4.1 25.6 1.0
HB1 A:ALA1129 4.1 35.1 1.0
HD21 A:LEU1117 4.2 26.5 0.5
HB2 A:LEU1119 4.2 37.3 1.0
H A:SER1130 4.2 32.9 1.0
CA A:LYS1118 4.2 27.4 1.0
O A:ALA1129 4.2 32.6 1.0
C A:ALA1129 4.3 33.1 1.0
H A:LEU1119 4.3 31.3 1.0
HE2 A:PHE1170 4.3 32.5 1.0
CE2 A:PHE1170 4.4 33.1 1.0
CA A:LEU1117 4.4 24.5 0.5
CA A:TYR1131 4.4 26.9 1.0
O A:SER1130 4.5 29.5 1.0
C A:LYS1118 4.5 28.6 1.0
C13 A:VMZ1507 4.5 56.0 1.0
CA A:LEU1117 4.5 27.3 0.5
N A:LEU1119 4.5 31.1 1.0
CB A:ALA1129 4.5 35.6 1.0
CD1 A:LEU1117 4.6 26.4 0.5
CD2 A:PHE1170 4.6 33.5 1.0
HD2 A:PHE1170 4.7 33.8 1.0
H A:LYS1118 4.7 25.6 1.0
HB2 A:LEU1117 4.7 24.8 0.5
HE2 A:MET1109 4.7 49.1 1.0
HD12 A:LEU1117 4.7 26.4 0.5
HD13 A:LEU1117 4.8 33.0 0.5
CZ A:PHE1170 4.9 31.7 1.0
H A:LEU1117 4.9 28.0 0.5
HD11 A:LEU1117 4.9 26.1 0.5
HE3 A:MET1109 5.0 50.2 1.0

Reference:

A.Vulpetti, P.Holzer, N.Schmiedeberg, P.Imbach-Weese, C.Pissot-Soldermann, G.J.Hollingworth, T.Radimerski, C.R.Thoma, T.M.Stachyra, M.Wojtynek, M.Maschlej, S.Chau, A.Schuffenhauer, C.Fernandez, M.Schroder, M.Renatus. Discovery of New Binders For DCAF1, An Emerging Ligase Target in the Targeted Protein Degradation Field Acs Med.Chem.Lett. 2023.
ISSN: ISSN 1948-5875
DOI: 10.1021/ACSMEDCHEMLETT.3C00104
Page generated: Wed Jul 26 17:07:15 2023

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy